Spatial distribution of repolarization and depolarization abnormalities evaluated by body surface potential mapping in patients with Brugada syndrome

PACE - Pacing and Clinical Electrophysiology

Volumn 29, Issue 10, 2006, Pages 1112-1121

  Yokokawa, Miki ^a   Takaki, Hiroshi ^a   Noda, Takashi ^a   Satomi, Kazuhiro ^a   Suyama, Kazuhiro ^a   Kurita, Takashi ^a   Kamakura, Shiro ^a   Shimizu, Wataru ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Body surface potential mapping; Brugada syndrome; Depolarization; Repolarization; ST segment

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOPRENALINE; PILSICAINIDE; SODIUM CHANNEL BLOCKING AGENT;

ADULT; ARTICLE; BRUGADA SYNDROME; CLINICAL ARTICLE; ELECTROCARDIOGRAPHY; FEMALE; HEART DEPOLARIZATION; HEART REPOLARIZATION; HEART RIGHT VENTRICLE OUTFLOW TRACT; HUMAN; MALE; QRS COMPLEX; ST SEGMENT; ST SEGMENT ELEVATION;

ADOLESCENT; ADULT; AGED; BODY SURFACE POTENTIAL MAPPING; BRUGADA SYNDROME; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 33750037297     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2006.00505.x     Document Type: Article

References (35)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome: A multicenter report. J Am Coll Cardiol 1992; 20:1391-1396.
2. Brugada J, Brugada P. Further characterization of the syndrome of right bundle branch block, ST segment elevation, and sudden cardiac death. J Cardiovasc Electrophysiol 1997; 8:325-331.
3. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in V1 through V3. Amarker for sudden death in patients without demonstrable structural heart disease. Circulation 1998; 97:457-460.
4. Wilde AA, Antzelevitch C, Borggrefe M, et al. Study group on the molecular basis of arrhythmias of the European society of cardiology. Proposed diagnostic criteria for the Brugada syndrome: Consensus report. Circulation 2002; 106:2514-2519.
5. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: Report of the second consensus conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005; 111:659-670.
6. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: Report of the second consensus conference. Heart Rhythm 2005; 2:429-440.
7. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada syndrome: Insights for risk stratification and management. Circulation 2002; 105:1342-1347.
8. Priori SG, Napolitano C, Memmi M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome:Aprospective evaluation of 52 families. Circulation 2000; 102:2509-2515.
9. Shimizu W, Aiba T, Kamakura S. Mechanisms of diseases: Current understanding and future challenges in Brugada syndrome. Nat Clin Pract Cardiovasc Med 2005; 2:408-414.
10. Nademanee K, Veerakul G, Nimmannit S, et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997; 96:2595-2600.
11. Pitzalis MV, Anaclerio M, Iacoviello M, et al. QT-interval prolongation in right precordial leads: An additional electrocardiographic hallmark of Brugada syndrome. J Am Coll Cardiol 2003; 42:1632-1637.
12. Smits JP, Eckardt L, Probst V, et al. Genotype-phenotype relationship in Brugada syndrome: Electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 2002; 40:350-356.
13. Nagase S, Kusano KF, Morita H, et al. Epicardial electrogram at the right ventricular outflow tract in patients with the Brugada syndrome: Using the epicardial leads. J Am Coll Cardiol 2002; 39:1992-1995.
14. Antzelevitch C. Late potentials and the Brugada syndrome. J Am Coll Cardiol 2002; 39:1996-1999.
15. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999; 100:1660-1666.
16. Antzelevitch C. The Brugada syndrome: Ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 2001; 12:268-272.
17. Meregalli PG, Wilde AA, Tan HL. Pathophysiological mechanisms of Brugada syndrome: Depolarization disorder, repolarization disorder, or more? Cardiovasc Res 2005; 67:367-378.
18. Roden DM, Wilde AA. Drug-induced J point elevation: A marker for genetic risk of sudden death or ECG curiosity? J Cardiovasc Electrophysiol 1999; 10:219-223.
19. Shimizu W, Kamakura S, Kurita T, Suyama K, Aihara N, Shimomura K. Influence of epinephrine, propranolol, and atrial pacing on spatial distribution of recovery time measured by body surface mapping in congenital long QT syndrome. J Cardiovasc Electrophysiol 1997; 8:1102-1114.
20. Shimizu W, Matsuo K, Takagi M, et al. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: Clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol 2000; 11:396-404.
21. Kamakura S, Shimizu W, Matsuo K, et al. Localization of the optimal ablation site of idiopathic ventricular tachycardia from right and left ventricular outflow tract by body surface electrocardiogram. Circulation 1998; 98:1525-1533.
22. Tahara N, Takaki H, Taguchi A, et al. Exercise-induced QRS prolongation in patients with mild coronary artery disease: Computer analysis of the digitized multilead ECGs. J Electrocardiol 1999; 32:206-211.
23. Sakuragi S, Takaki H, Taguchi A, et al. Diagnostic value of the recovery time-course of ST slope on exercise in discriminating false-from true-positive ST-segment depressions. Circ J 2004; 68:915-922.
24. Krishnan SC, Josephson ME. ST segment elevation induced by class IC antiarrhythmic agents: Underlying electrophysiologic mechanisms and insights into drug-induced proarrhythmia. J Cardiovasc Electrophysiol 1998; 9:1167-1172.
25. Fujiki A, Usui M, Nagasawa H, Mizumaki K, Hayashi H, Inoue H. ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drug: Insight into the mechanism of Brugada syndrome. J Cardiovasc Electrophysiol 1999; 10:214-218.
26. Shimizu W, Antzelevitch C, Suyama K, et al. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2000; 11:1320-1329.
27. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27:1061-1070.
28. Eckardt L, Bruns HJ, Paul M, et al. Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome. J Cardiovasc Electrophysiol 2002; 13:742-749.
29. Bruns HJ, Eckardt L, Vahlhaus C, et al. Body surface potential mapping in patients with Brugada syndrome: Right precordial ST segment variations and reverse changes in left precordial leads. Cardiovasc Res 2002; 54:58-66.
30. Hisamatsu K, Kusano KF, Morita H, et al. Relationships between depolarization abnormality and repolarization and abnormality in patients with Brugada syndrome: Using bodysurface signal-averaged electrocardiography and body surface maps. J Cardiovasc Electrophysiol 2004; 15:870-876.
31. Izumida N, Asano Y, Doi S, et al. Changes in body surface potential distributions induced by isoproterenol and Na channel blockers in patients with the Brugada syndrome. Int J Cardiol 2004; 95:261-268.
32. Haws CW, Lux RL. Correlation between in vivo transmembrane action potential durations and activation-recovery intervals from electrograms: Effects of interventions that alter repolarization time. Circulation 1990; 81:281-288.
33. Coronel R, Casini S, Koopmann TT, et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: A combined electrophysiological, genetic, histopathologic, and computational study. Circulation 2005; 112:2769-2777.
34. Frustaci A, Priori SG, Pieroni M, et al. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 2005; 112:3680-3687.
35. Aiba T, Shimizu W, Hidaka I, et al. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: High resolution optical mapping study. J Am Coll Cardiol 2006; 47:2074-2085.